BARCLAYS PLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 46 filers reported holding OVID THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$41
+2.5%
10,780
-9.8%
0.00%
Q2 2023$40
-99.9%
11,955
+45.5%
0.00%
Q3 2021$28,000
-79.6%
8,218
-76.7%
0.00%
Q2 2021$137,000
-14.9%
35,227
-12.1%
0.00%
Q1 2021$161,000
+360.0%
40,077
+160.9%
0.00%
Q4 2020$35,000
-76.2%
15,359
-40.1%
0.00%
Q3 2020$147,000
-15.0%
25,635
+8.7%
0.00%
Q2 2020$173,00023,574
+8729.2%
0.00%
Q2 2019$0
-100.0%
267
-92.8%
0.00%
Q1 2019$7,000
-75.0%
3,723
-24.6%
0.00%
Q3 2018$28,000
+154.5%
4,938
+247.7%
0.00%
Q2 2018$11,000
-38.9%
1,420
-44.1%
0.00%
Q1 2018$18,000
+125.0%
2,538
+216.9%
0.00%
Q4 2017$8,000
+700.0%
801
+578.8%
0.00%
Q3 2017$1,000118
+2850.0%
0.00%
Q2 2017$040.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders